Thomas Goetz
11.5K posts
@tgoetz
Journalist, entrepreneur, haver of notions.
Leading with science means starting with a story, said journalist @tgoetz during a fireside chat with @annewoj23. He spoke about his podcast Drug Story, how to make science accessible for audiences, and how 23andMe's work continues to help people better understand genomics.
“Lock-in” isn’t just an Apple thing. Thomas Goetz (@tgoetz), creator of the Drug Story podcast, explains how EpiPen built a moat: train school nurses and teachers on one device, and the “similar but different” competitor becomes harder to adopt. @pescami #healthcare #pharma #economics
Today on the Gist: Thomas Goetz (@tgoetz) joins the show to discuss his new podcast Drug Story, starting with the chain from FDR’s death to cholesterol science, statins, and the cold math behind drug effectiveness. The conversation moves through Lipitor and EpiPens to show how evolving medical knowledge, good intentions, and pharmaceutical incentives can quietly reshape public health at massive scale. Plus, Trump is perhaps rethinking his Minnesota deployments, as the fire trucks exit. In the spiel a look at why the word “pretext” keeps surfacing in descriptions of Trump administration ICE actions, especially in Minnesota. What the term actually means, why it is often misapplied, and what its ubiquity reveals about how this administration justifies force before retreating. @pescami #drugstory #ice #Minneapolis #lipitor #epipens #PublicHealth
Why was there such an upsurge in peanut allergies? Learn about the fascinating world of prescription drugs -- some of the most important & complex elements in our world -- with science journalist Thomas Goetz (@tgoetz). eagleman.com/podcast/137
As always, thoughtful @tgoetz, arguing in @statnews that pursuit of "magic bullet" (latest eg: GLP-1s) distracts us from (a) non-pharmacological rx & (b) broader underlying causes. statnews.com/2026/01/08/dru… Makes sense-BUT- prior to GLP-1s, how was that working out for obesity?
